GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Verici Dx PLC (LSE:VRCI) » Definitions » Other Current Receivables

Verici Dx (LSE:VRCI) Other Current Receivables : £0.09 Mil (As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Verici Dx Other Current Receivables?

Verici Dx's Other Current Receivables for the quarter that ended in Jun. 2023 was £0.09 Mil.

Verici Dx's quarterly Other Current Receivables declined from Jun. 2022 (£0.16 Mil) to Dec. 2022 (£0.15 Mil) but then stayed the same from Dec. 2022 (£0.15 Mil) to Jun. 2023 (£0.09 Mil).

Verici Dx's annual Other Current Receivables increased from Dec. 2020 (£0.09 Mil) to Dec. 2021 (£0.19 Mil) but then declined from Dec. 2021 (£0.19 Mil) to Dec. 2022 (£0.15 Mil).

Verici Dx Other Current Receivables Historical Data

The historical data trend for Verici Dx's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verici Dx Other Current Receivables Chart

Verici Dx Annual Data
Trend Dec20 Dec21 Dec22
Other Current Receivables
0.09 0.19 0.15

Verici Dx Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23
Other Current Receivables 0.16 0.19 0.16 0.15 0.09

Verici Dx Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Verici Dx Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Verici Dx's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Verici Dx (LSE:VRCI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Verici Dx PLC (LSE:VRCI) » Definitions » Other Current Receivables
Comparable Companies
LSE:ABDX LSE:GDR LSE:GENI LSE:PRM LSE:LLAI LSE:AGL TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN DGX WAT EXAS
Traded in Other Exchanges
VRCDF:USA
Address
19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
Website
https://www.vericidx.com
Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies which will help understand the outcomes of an organ transplant surgery. There are two products for clinical validation and commercialization: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection; and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels. The business of the Group comprises a single activity, that of the development of prognostic and diagnostic tests for kidney transplant patients.

Verici Dx (LSE:VRCI) Headlines

No Headlines